National Drug Administration: Nigerian Shuli adverse reaction monitoring is not abnormal
Release time: 2011-02-21 & nbsp & nbsp & nbsp Source:
Business Club February 20th News
Recently on Removal Anti -fever Nimi Shuli may lead to liver damage.，But there is no official statement in this medicine that this medicine has not been withdrawn。Yesterday，The National Food and Drug Administration exclusively sent a fax to the reporter，It means from the current adverse reaction monitoring，No abnormal situation occurs，National Pharmaceutical Adverse Reaction Center is organizing experts to further demonstrate stake betting appits safety。stake betting appGuangdong Food and Drug Administration also said，During 9 years, a total of 133 adverse reactions were monitored in the province，But there are no cases of liver function damage in children。
Yesterday, the relevant person in charge of Kangzhi Pharmaceutical told this reporter，This incident is actually a competitor in pounding，and a global pharmaceutical giant is the protagonist。Current，Kangzhi Pharmaceutical has issued a complaint letter for the company's suspected improper competition to the Hainan Provincial Bureau of Industry and Commerce，and posted a lawyer's letter on the company's official website。The global pharmaceutical giant responded to the reporter yesterday evening，The company is currently understanding the situation，There will be progress in progress。
A pharmaceutical giant was accused of hacking behind the scenes
Our reporter learned on the website of the State Food and Drug Administration，A total of 55 various medicines with approved Nimei Shuli。Among them, the listed company Kangzhi Pharmaceutical is the largest manufacturer，The proportion of "Ruizhi Qing" brand Nimei Schihachad the annual sales of the company's annual sales of the company's annual sales is as high as about 80 %。Nimei Shuli incident，Many media directly point the finger at Kangzhi Pharmaceutical。
Yesterday, stake online sports bettinga person in charge of a surname of Xiao Kangzhi Pharmaceutical told reporters，This is not a simple drug adverse reaction，Instead, competitors are pounding。He also said，This pharmaceutical factory sends a warning SMS for doctors in major hospitals，Calculating Nimei Shuli is suspected of unsafe。And the official website of this global pharmaceutical giant also obviously disables Nimei Shuli logo。"But now this logo has been withdrawn，But we all save evidence。"Mr. Xiao said。
It is understood，Anti -fever medicine produced by the pharmaceutical giant is also a commonly used child antipyretic medicine for Chinese mothers，And Kangzhi Pharmaceutical's "Ruizhi Qing" can be said to be one of its biggest competitors in China。
The person in charge of Xiao also admits to reporters，Hainan Kangzhi Pharmaceutical has officially submitted to the Hainan Industrial and Commercial Bureau to suppress the complaint letter from the leading company of Hainan Pharmaceuticals through improper competition.。Will the next come to the court? The person in charge said that the legal approach is being studied。
Kangzhi Pharmaceutical Loss Heavy
The company also posted a lawyer's letter on its official website and said: Some companies and units conduct non -adefeating behaviors on "Nimei Shuli Granules" through the media，has My stake betting appStake Sports Bettingcaused a serious adverse effect on the reputation of "Ruizhiqing"，Its behavior has violated the law，The company reserves the right to investigate its legal responsibility。
It is reported，The incident has a profound impact on Kangzhi Pharmaceutical。Because "Ruizhiqing" is almost the company's lifeline，account for more than 80 % of its sales。February 14，Kangzhi Pharmaceutical suspended trading and issued announcement to clarify，means that the "Nimei Shuli Granules" mentioned by the media will lead to severe liver damage、Death cases and other contents are seriously inconsistent with facts，and "Ruizhiqing" produced by Hainan Kangzhi Pharmaceutical Co., Ltd.。
And Kangzhi Pharmaceutical's stock price is also affected by this，From the beginning of the 15th, from now on，Four days of trading days, the stock price fell for three days，Falling 3.7%after closing yesterday。
Security will further demonstrate
Also News According to Xinhua News Agency reporters, I learned from the National Food and Drug Administration News Office of the State Food and Drug Administration，Nimei Shuli is always under the close monitoring of the National Pharmaceutical Adverse Reaction Monitoring Center，Its safety issues will be further demonstrated。
The State Food and Drug Administration made a modification of the Nimei My stake betting appShuli instructions in stake online sports betting2008，For indications、Drugs people、Usage Dosage and other matters have been restricted。National Pharmaceutical Adverse Reaction Monitoring Center also monitors and follow the relevant testing data at home and abroad。
Recently on Removal Anti -fever Nimi Shuli may lead to liver damage.，But there is no official statement in this medicine that this medicine has not been withdrawn。Yesterday，The National Food and Drug Administration exclusively sent a fax to the reporter，It means from the current adverse reaction monitoring，No abnormal situation occurs，National Pharmaceutical Adverse Reaction Center is organizing experts to further demonstrate stake betting appits safety。stake betting appGuangdong Food and Drug Administration also said，During 9 years, a total of 133 adverse reactions were monitored in the province，But there are no cases of liver function damage in children。
Yesterday, the relevant person in charge of Kangzhi Pharmaceutical told this reporter，This incident is actually a competitor in pounding，and a global pharmaceutical giant is the protagonist。Current，Kangzhi Pharmaceutical has issued a complaint letter for the company's suspected improper competition to the Hainan Provincial Bureau of Industry and Commerce，and posted a lawyer's letter on the company's official website。The global pharmaceutical giant responded to the reporter yesterday evening，The company is currently understanding the situation，There will be progress in progress。
A pharmaceutical giant was accused of hacking behind the scenes
Our reporter learned on the website of the State Food and Drug Administration，A total of 55 various medicines with approved Nimei Shuli。Among them, the listed company Kangzhi Pharmaceutical is the largest manufacturer，The proportion of "Ruizhi Qing" brand Nimei Schihachad the annual sales of the company's annual sales of the company's annual sales is as high as about 80 %。Nimei Shuli incident，Many media directly point the finger at Kangzhi Pharmaceutical。
Yesterday, stake online sports bettinga person in charge of a surname of Xiao Kangzhi Pharmaceutical told reporters，This is not a simple drug adverse reaction，Instead, competitors are pounding。He also said，This pharmaceutical factory sends a warning SMS for doctors in major hospitals，Calculating Nimei Shuli is suspected of unsafe。And the official website of this global pharmaceutical giant also obviously disables Nimei Shuli logo。"But now this logo has been withdrawn，But we all save evidence。"Mr. Xiao said。
It is understood，Anti -fever medicine produced by the pharmaceutical giant is also a commonly used child antipyretic medicine for Chinese mothers，And Kangzhi Pharmaceutical's "Ruizhi Qing" can be said to be one of its biggest competitors in China。
The person in charge of Xiao also admits to reporters，Hainan Kangzhi Pharmaceutical has officially submitted to the Hainan Industrial and Commercial Bureau to suppress the complaint letter from the leading company of Hainan Pharmaceuticals through improper competition.。Will the next come to the court? The person in charge said that the legal approach is being studied。
Kangzhi Pharmaceutical Loss Heavy
The company also posted a lawyer's letter on its official website and said: Some companies and units conduct non -adefeating behaviors on "Nimei Shuli Granules" through the media，has My stake betting appStake Sports Bettingcaused a serious adverse effect on the reputation of "Ruizhiqing"，Its behavior has violated the law，The company reserves the right to investigate its legal responsibility。
It is reported，The incident has a profound impact on Kangzhi Pharmaceutical。Because "Ruizhiqing" is almost the company's lifeline，account for more than 80 % of its sales。February 14，Kangzhi Pharmaceutical suspended trading and issued announcement to clarify，means that the "Nimei Shuli Granules" mentioned by the media will lead to severe liver damage、Death cases and other contents are seriously inconsistent with facts，and "Ruizhiqing" produced by Hainan Kangzhi Pharmaceutical Co., Ltd.。
And Kangzhi Pharmaceutical's stock price is also affected by this，From the beginning of the 15th, from now on，Four days of trading days, the stock price fell for three days，Falling 3.7%after closing yesterday。
Security will further demonstrate
Also News According to Xinhua News Agency reporters, I learned from the National Food and Drug Administration News Office of the State Food and Drug Administration，Nimei Shuli is always under the close monitoring of the National Pharmaceutical Adverse Reaction Monitoring Center，Its safety issues will be further demonstrated。
The State Food and Drug Administration made a modification of the Nimei My stake betting appShuli instructions in stake online sports betting2008，For indications、Drugs people、Usage Dosage and other matters have been restricted。National Pharmaceutical Adverse Reaction Monitoring Center also monitors and follow the relevant testing data at home and abroad。
